First time in human clinical test using a personalized tissue-engineered blood vessel to treat chronical illness in a vein.

2024-520148-40-00 Protocol TECVI-1 Human pharmacology (Phase I) - First administration to humans Ended

Start 25 Feb 2021 · End 11 Jun 2025 · Status Ended · 1 EU/EEA countries · 11 sites · Protocol TECVI-1

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - First administration to humans
Status Ended
Participants planned 15
Countries 1
Sites 11

Chronic venous insufficiency

Key facts

Sponsor
VeriGraft AB
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Cardiovascular Diseases [C14]
Trial duration
25 Feb 2021 → 11 Jun 2025
Decision date (initial)
2024-12-23
Transition trial
Yes
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

External identifiers

EU CT number
2024-520148-40-00
EudraCT number
2020-003778-28

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Chronic venous insufficiency

VersionLevelCodeTermSystem organ class
21.1 LLT 10066682 Chronic venous insufficiency 10047065

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

VeriGraft AB

Sponsor organisation
VeriGraft AB
Address
Arvid Wallgrens Backe 20, Goteborgs Annedal Goteborgs Annedal
City
Goteborg
Postcode
413 46
Country
Sweden

Scientific contact point

Organisation
VeriGraft AB
Contact name
Raimund Strehl

Public contact point

Organisation
VeriGraft AB
Contact name
Raimund Strehl

Locations

1 EU/EEA country · 11 investigational sites

By country

CountryMS statusPlanned subjectsSites
Spain Ended 15 11
Rest of world 0

Investigational sites

Spain

11 sites · Ended
Hospital Universitario Virgen De Las Nieves
Servicio de Angiología y Cirugía vascular, Avenida De Las Fuerzas Armadas 2, 18014, Granada
Hospital Universitario Puerta Del Mar
Servicio de Angiología y Cirugía vascular, Avenida De Ana De Viya 21, 11009, Cadiz
Hospital Universitario Clinico San Cecilio
Servicio de Angiología y Cirugía vascular, Avenida Del Conocimiento S/n, Poligono Industrial De Ciencias De La Salud, Granada
Hospital Universitario De Jaen
Servicio de Angiología y Cirugía vascular, Avenida Del Ejercito Espanol 10, 23007, Jaen
Hospital Universitario Torrecardenas
Servicio de Angiología y Cirugía vascular, Calle Paraje Torrecardenas S/n, 04009, Almeria
Hospital Universitario Virgen De La Victoria
Servicio de Angiología y Cirugía vascular, Calle Del Arroyo Teatinos Sn, 29010, Malaga
Hospital Universitario Virgen De Valme
Servicio de Angiología y Cirugía vascular, Avenida Bellavista S/n, 41014, Sevilla
University Hospital Virgen Del Rocio S.L.
Servicio de Angiología y Cirugía vascular, Avenida De Manuel Siurot S/n, 41013, Sevilla
Hospital Del Mar
Servicio de Angiología y Cirugía vascular, Passeig Maritim De La Barceloneta 25-29, 08003, Barcelona
Hospital Universitari Vall D Hebron
Servicio de Angiología y Cirugía vascular, Passeig De La Vall D'Hebron 119-129, 08035, Barcelona
Bellvitge University Hospital
Servicio de Angiología y Cirugía vascular, Carrer De La Feixa Llarga S/N, 08907, L'Hospitalet De Llobregat

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Spain 2021-02-25 2025-06-11 2021-10-18 2025-05-14

Application history

2 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-12-16 Spain Acceptable
2024-12-23
2024-12-23
2 SUBSTANTIAL MODIFICATION SM-1 2025-02-06 Spain Acceptable
2025-05-14
2025-05-14